Bonus BioGroup Ltd. (BBIXF)

Market Cap	189.91M +237.8%
Revenue (ttm)	n/a
Net Income	-7.57M
EPS	n/a
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	10,990
Open	0.1500
Previous Close	0.1000
Day's Range	0.1500 - 0.1500
52-Week Range	0.0001 - 0.1500
Beta	0.74
RSI	66.57
Earnings Date	Mar 30, 2026

About Bonus BioGroup

Bonus BioGroup Ltd., a clinical-stage biotechnology company, develops products based on tissue engineering and cell therapy. The company’s products under development include BonoFill for the treatment of bone tissue regeneration in maxillofacial and orthopedic indications, and defects in limb and jaw bones which is in Phase II clinical trial, as well as in a preclinical stage for the treatment of bone augmentation in osteoporosis patients. It also develops MesenCure for the treatment of COVID patients suffering from pneumonia and ARDS which is ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1981
• Employees: 37
• Stock Exchange: OTCMKTS
• Ticker Symbol: BBIXF

Financial Performance

Financial numbers in ILS